Last update 21 Nov 2024

JCXH-212

Overview

Basic Info

Drug Type
Therapeutic vaccine, mRNA vaccine
Synonyms
Target
IL-12
Mechanism
IL-12 modulators(Interleukin-12 modulators)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmSolid tumor
Inactive Indication-
Originator Organization
Jiachen Xihai (Hangzhou) Biotechnology Co., Ltd.Jiachen Xihai (Hangzhou) Biotechnology Co., Ltd.
Active Organization
Beijing Cancer HospitalJiachen Xihai (Hangzhou) Biotechnology Co., Ltd.Jiachen Xihai (Hangzhou) Biotechnology Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with JCXH-212
NCT05579275 / RecruitingEarly Phase 1IIT
A Single-center, Open-label Study to Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
100 Clinical Results associated with JCXH-212
Login to view more data
100 Translational Medicine associated with JCXH-212
Login to view more data
100 Patents (Medical) associated with JCXH-212
Login to view more data
100 Deals associated with JCXH-212
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
CN
Jiachen Xihai (Hangzhou) Biotechnology Co., Ltd.Jiachen Xihai (Hangzhou) Biotechnology Co., Ltd.
06 Nov 2023
Solid tumorPhase 1
CN
Beijing Cancer Hospital
06 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free